Zhejiang Jolly Pharmaceutical Co Ltd Financial Flexibility Index
Zhejiang Jolly Pharmaceutical Co Ltd financial flexibility index. Zhejiang Jolly Pharmaceutical Co Ltd (300181) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥39.97 Million (operating CF CN¥-23.58 Million minus capex CN¥63.55 Million) represents 0% of total liabilities (CN¥1.46 Billion). See how much free cash does Zhejiang Jolly Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Zhejiang Jolly Pharmaceutical Co Ltd (2007–2025)
Financial flexibility index of Zhejiang Jolly Pharmaceutical Co Ltd from 2007 to 2025. Historical Financial Flexibility Index trend for Zhejiang Jolly Pharmaceutical Co Ltd across 19 annual periods. Check Zhejiang Jolly Pharmaceutical Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Jolly Pharmaceutical Co Ltd Financial Flexibility Index by Year (2007–2025)
Zhejiang Jolly Pharmaceutical Co Ltd financial flexibility index by year from 2007 to 2025. Year-by-year free cash flow to debt coverage for Zhejiang Jolly Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 300181 cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.48x | CN¥698.95 Million | CN¥411.80 Million | CN¥1.47 Billion | ▼ -0.5% |
| 2024 | 0.48x | CN¥559.94 Million | CN¥297.05 Million | CN¥1.17 Billion | ▼ -3.0% |
| 2023 | 0.49x | CN¥420.18 Million | CN¥288.46 Million | CN¥853.09 Million | ▼ -12.8% |
| 2022 | 0.56x | CN¥496.63 Million | CN¥318.59 Million | CN¥879.19 Million | ▲ +8.1% |
| 2021 | 0.52x | CN¥399.75 Million | CN¥251.80 Million | CN¥765.31 Million | ▲ +16.0% |
| 2020 | 0.45x | CN¥338.04 Million | CN¥279.69 Million | CN¥750.43 Million | ▲ +70.9% |
| 2019 | 0.26x | CN¥169.40 Million | CN¥128.94 Million | CN¥642.86 Million | ▼ -17.6% |
| 2018 | 0.32x | CN¥232.21 Million | CN¥78.28 Million | CN¥726.50 Million | ▲ +61.7% |
| 2017 | 0.20x | CN¥130.90 Million | CN¥6.51 Million | CN¥662.06 Million | ▼ -44.5% |
| 2016 | 0.36x | CN¥201.55 Million | CN¥58.30 Million | CN¥566.00 Million | ▲ +19.9% |
| 2015 | 0.30x | CN¥123.21 Million | CN¥97.13 Million | CN¥414.94 Million | ▲ +73.6% |
| 2014 | 0.17x | CN¥52.99 Million | CN¥13.70 Million | CN¥309.75 Million | ▼ -45.6% |
| 2013 | 0.31x | CN¥53.23 Million | CN¥29.50 Million | CN¥169.38 Million | ▼ -26.4% |
| 2012 | 0.43x | CN¥67.55 Million | CN¥30.51 Million | CN¥158.27 Million | ▼ -8.9% |
| 2011 | 0.47x | CN¥74.98 Million | CN¥13.65 Million | CN¥159.99 Million | ▼ -35.9% |
| 2010 | 0.73x | CN¥103.46 Million | CN¥64.78 Million | CN¥141.47 Million | ▲ +52.1% |
| 2009 | 0.48x | CN¥63.49 Million | CN¥43.89 Million | CN¥132.07 Million | ▲ +44.0% |
| 2008 | 0.33x | CN¥43.66 Million | CN¥31.16 Million | CN¥130.76 Million | ▲ +41.7% |
| 2007 | 0.24x | CN¥25.17 Million | CN¥16.05 Million | CN¥106.79 Million | — |